Owing to success of the first edition and to the rapid development of new drugs for treating Alzheimer's disease, this third edition offers an updated collection of views on the subject from leading clinicians and researchers.
Owing to success of the first edition and to the rapid development of new drugs for treating Alzheimer's disease, this third edition offers an updated...
David C. Thomasma Serge Gauthier David N. Weisstub
Culture, Health, and Social Change is the first of three volumes on Aging conceived for the International Library of Ethics, Law, and theNew Medicine. Leading scholars from a range of disciplines contest some of the predominant paradigms on aging, and critically assess modern trends in social health policy. How we approach and understand "aging" will have indelible effects on existing and future elder citizens. Acknowledging the cultural variances that exist in the human experience of aging is therefore of vital importance in order to...
Culture, Health, and Social Change is the first of three volumes on Aging conceived for the International Librar...
David C. Thomasma Serge Gauthier David N. Weisstub
Caring for Our Elders is the second of three volumes on Aging conceived for the International Library of Ethics, Law, and the NewMedicine. Leading scholars from a range of disciplines address some of the major issues in elder care facing modern nations: familial duties of care, the future of social welfare systems, housing, dementia, abuse and neglect.
Caring for Our Elders is the second of three volumes on Aging conceived for the International Library of Ethics,...
David C. Thomasma Serge Gauthier David N. Weisstub
Decisions at the End of Life is the last volume in a trilogy on Aging conceived for the International Library of Ethics, Law, and the NewMedicine. Leading scholars from a range of disciplines examine some of the most emotive topics in the study of aging: assessing quality of life, improving end-of-life care, palliative care, euthanasia, and consent to research.
Decisions at the End of Life is the last volume in a trilogy on Aging conceived for the International Library of Ethics, Law, an...
Given the increased attention by clinicians, researchers and the pharmaceutical industry to the management and treatment of dementia not only in the elderly but also in increasingly younger populations, the demands for effective evidence-based pharmaceutical control of dementia and quantitative assessment of outcomes have increased. Since some first steps in the early 1960's to the controversial landmark paper of Summers and colleagues, to the most recent trials, it is clear both that much progress has been made, and that much remains to be done. This book is written to take stock of what is...
Given the increased attention by clinicians, researchers and the pharmaceutical industry to the management and treatment of dementia not only in the e...
Vascular cognitive impairment is the second most common cause of dementia after Alzheimer's disease and is expected to grow in prevalence with the aging global population. The purpose of this authoritative book is to give a broad clinical perspective on vascular cognitive impairment and thus create a foundation for the implementation of good dementia care. The book focuses on pathophysiology, diagnosis, treatment and prevention. It demonstrates the underlying causes of the disorder, such as the manner in which vascular risk-factors influence the onset of vascular cognitive impairment. The...
Vascular cognitive impairment is the second most common cause of dementia after Alzheimer's disease and is expected to grow in prevalence with the agi...